Actively Recruiting
Adaptive Deep Brain Stimulation Using Brain Rhythms for Treatment of Essential Tremor
Led by University of Florida · Updated on 2026-07-30
25
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating an adaptive deep brain stimulation aDBS approach for patients with medically refractory essential tremor ET, a condition where tremor is difficult to control with medication. The study aims to assess whether automatically turning off DBS during sleep based on circadian brain signals can improve long-term treatment by reducing side effects, habituation, and battery use. This trial uses a double-blinded crossover design to compare adaptive DBS to conventional continuous DBS. Participants implanted with the Medtronic Percept PC device and DBS leads in the thalamus will first have brain signals recorded for one month to identify sleep-related rhythms. Then, they will undergo two weeks of adaptive DBS where stimulation turns off during sleep, followed by two weeks of conventional continuous DBS, or vice versa, in randomized order. After this crossover period, patients preferring adaptive DBS may continue it for six months to evaluate long-term tolerability. During the approximately eight-month study, participants will attend seven visits for device programming, symptom assessments, and monitoring side effects. Researchers will use clinical scales, patient questionnaires, and wearable devices to track tremor severity, sleep quality, mood, cognition, and quality of life. Device energy use and adverse events will also be measured to assess safety and feasibility of the adaptive DBS approach.
CONDITIONS
Brief Title
Circadian Adaptive DBS in Essential Tremor
Research Team
J
Julia C Gonzalez, BA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here